CSIMarket
 


Abeona Therapeutics Inc.  (ABEO)
Other Ticker:  
 
 

ABEO's Net Income Growth by Quarter and Year

Abeona Therapeutics's Net Income results by quarter and year




ABEO Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -20.09 -8.45 -7.00
III Quarter September - -16.42 -5.34 -2.62
II Quarter June -23.92 -11.70 -8.28 -6.70
I Quarter March -18.56 -8.46 -5.25 -5.54
FY   -42.48 -56.67 -27.32 -21.86



ABEO Net Income second quarter 2019 Y/Y Growth Comment
Abeona Therapeutics Inc. in the second quarter recorded net loss of $ -23.92 millions.

According to the results reported in the second quarter, Abeona Therapeutics Inc. achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Abeona Therapeutics Inc.' s Net Income no change of % ranks overall at the positon no. in the second quarter.




ABEO Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Abeona Therapeutics's second quarter 2019 Net Income $ -23.92 millions ABEO's Income Statement
Abeona Therapeutics's second quarter 2018 Net Income $ -11.70 millions Quarterly ABEO's Income Statement
New: More ABEO's historic Net Income Growth >>


ABEO Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Abeona Therapeutics's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ABEO's II. Quarter Q/Q Net Income Comment
Current results of -23.92 millions by Abeona Therapeutics Inc. look even worse considering the -18.56 millions net loss in the previous quarter.

Within Major Pharmaceutical Preparations industry Abeona Therapeutics Inc. achieved highest sequential Net Income growth. While Abeona Therapeutics's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ABEO's II. Quarter Q/Q Net Income Comment
II. Quarter 2019 net loss of -23.92 millions by Abeona Therapeutics Inc. appear even less good considering the -18.56 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Abeona Therapeutics Inc. achieved highest sequential Net Income growth. While Abeona Therapeutics's Net Income growth quarter on quarter, overall rank is .


Abeona Therapeutics's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Net Income 12 Months Ending $ -78.99 $ -66.76 $ -56.67 $ -45.03 $ -33.96
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Abeona Therapeutics Inc.' has realized cumulative trailing twelve months net loss of $ -79 millions in the Jun 30 2019 period.
The business is detiriorating as the cumulative net loss is becoming larger from $ -66.76 millions in TTM ending quarter Mar 31 2019 and $ -18.56 millions for the twelve months ending in the quarter Jun 30 2018 Grace  N. Robinson mentioned.

Abeona Therapeutics Inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Abeona Therapeutics Inc.' has realized cumulative trailing twelve months net loss of $ -79 millions in the Jun 30 2019 period.
The business is detiriorating as the cumulative net loss is becoming larger from $ -66.76 millions in the twelve months ending a quarter before and $ -18.56 millions for the twelve months ending in the quarter Jun 30 2018 Grace  N. Robinson mentioned.

Abeona Therapeutics Inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ABEO's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ABEO's Competitors
Net Income Growth for Abeona Therapeutics's Suppliers
Net Income Growth for ABEO's Customers

You may also want to know
ABEO's Annual Growth Rates ABEO's Profitability Ratios ABEO's Asset Turnover Ratio ABEO's Dividend Growth
ABEO's Roe ABEO's Valuation Ratios ABEO's Financial Strength Ratios ABEO's Dividend Payout Ratio
ABEO's Roa ABEO's Inventory Turnover Ratio ABEO's Growth Rates ABEO's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2019
Lifeloc Technologies, Inc  179.95 %$ 179.947 millions
Integra Lifesciences Holdings Corp  161.39 %$ 161.392 millions
Eagle Pharmaceuticals, Inc.  152.91 %$ 152.915 millions
Vanda Pharmaceuticals Inc.  149.97 %$ 149.967 millions
Ani Pharmaceuticals Inc  137.13 %$ 137.126 millions
Cellect Biotechnology Ltd.  125.92 %$ 125.916 millions
Bio-rad Laboratories, Inc.  123.40 %$ 123.401 millions
Resmed Inc  118.31 %$ 118.309 millions
Staar Surgical Co  113.88 %$ 113.880 millions
Incyte Corp  101.01 %$ 101.012 millions
Genomic Health, Inc  92.22 %$ 92.221 millions
Surgery Partners, Inc.  87.94 %$ 87.935 millions
Semler Scientific, Inc.  80.25 %$ 80.248 millions
Medpace Holdings, Inc.  65.71 %$ 65.711 millions
Biogen Inc.  63.29 %$ 63.290 millions
Galmed Pharmaceuticals Ltd.  55.27 %$ 55.270 millions
Iradimed Corp  54.16 %$ 54.162 millions
Merck & Co., Inc.  54.08 %$ 54.079 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GDSI's Profile

Stock Price

GDSI's Financials

Business Description

Fundamentals

Charts & Quotes

GDSI's News

Suppliers

GDSI's Competitors

Customers & Markets

Economic Indicators

GDSI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071